{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:04:00Z","timestamp":1794953040733,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["A-2690"],"award-info":[{"award-number":["A-2690"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS082079"],"award-info":[{"award-number":["NS082079"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS016367"],"award-info":[{"award-number":["NS016367"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS114065"],"award-info":[{"award-number":["NS114065"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS126420"],"award-info":[{"award-number":["NS126420"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS049206"],"award-info":[{"award-number":["NS049206"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS127866"],"award-info":[{"award-number":["NS127866"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS105709"],"award-info":[{"award-number":["NS105709"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS119471"],"award-info":[{"award-number":["NS119471"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001671","name":"Hereditary Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X018253\/1"],"award-info":[{"award-number":["MR\/X018253\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L010305\/1"],"award-info":[{"award-number":["MR\/L010305\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41588-025-02191-5","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T05:02:15Z","timestamp":1749445335000},"page":"1426-1436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Genetic modifiers of somatic expansion and clinical phenotypes in Huntington\u2019s disease highlight shared and tissue-specific effects"],"prefix":"10.1038","volume":"57","author":[{"name":"Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Group 1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5799-0787","authenticated-orcid":false,"given":"Jong-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachariah L.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Wan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9330-3346","authenticated-orcid":false,"given":"Jae-Hyun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4569-7377","authenticated-orcid":false,"given":"Yukyeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo Eun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Lucente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihn Sik","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6744-2805","authenticated-orcid":false,"given":"Ricardo","family":"Mouro Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James V.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayalakshmi S.","family":"Mysore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Elezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayla","family":"Ruliera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Gillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8259-5796","authenticated-orcid":false,"given":"Vanessa C.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcy E.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0681-9263","authenticated-orcid":false,"given":"James F.","family":"Gusella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Group 2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1601-5277","authenticated-orcid":false,"given":"Anna","family":"Gatseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7663-4080","authenticated-orcid":false,"given":"Marc","family":"Ciosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilija","family":"Lomeikaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9145-1736","authenticated-orcid":false,"given":"Hossameldin","family":"Loay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8298-8264","authenticated-orcid":false,"given":"Darren G.","family":"Monckton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Group 3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3178-8924","authenticated-orcid":false,"given":"Christopher","family":"Wills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9804-2131","authenticated-orcid":false,"given":"Thomas H.","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0870-9412","authenticated-orcid":false,"given":"Peter","family":"Holmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Group 4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4048-1278","authenticated-orcid":false,"given":"Seung","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Group 5","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Orth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Bernhard","family":"Landwehrmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane S.","family":"Paulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Ray","family":"Dorsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8365-2674","authenticated-orcid":false,"given":"Richard H.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"2191_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"Huntington\u2019s Disease Collaborative Research Group.","year":"1993","unstructured":"Huntington\u2019s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72, 971\u2013983 (1993).","journal-title":"Cell"},{"key":"2191_CR2","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cell.2019.06.036","volume":"178","author":"Genetic Modifiers of Huntington\u2019s Disease Consortium.","year":"2019","unstructured":"Genetic Modifiers of Huntington\u2019s Disease Consortium. CAG repeat not polyglutamine length determines timing of Huntington\u2019s disease onset. Cell 178, 887\u2013900.e14 (2019).","journal-title":"Cell"},{"key":"2191_CR3","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.ajhg.2019.04.007","volume":"104","author":"GEB Wright","year":"2019","unstructured":"Wright, G. E. B. et al. Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease. Am. J. Hum. Genet. 104, 1116\u20131126 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"2191_CR4","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ebiom.2019.09.020","volume":"48","author":"M Ciosi","year":"2019","unstructured":"Ciosi, M. et al. A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes. EBioMedicine 48, 568\u2013580 (2019).","journal-title":"EBioMedicine"},{"key":"2191_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","volume":"162","author":"Genetic Modifiers of Huntington\u2019s Disease Consortium.","year":"2015","unstructured":"Genetic Modifiers of Huntington\u2019s Disease Consortium. Identification of genetic factors that modify clinical onset of Huntington\u2019s disease. Cell 162, 516\u2013526 (2015).","journal-title":"Cell"},{"key":"2191_CR6","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.ajhg.2022.06.002","volume":"109","author":"JM Lee","year":"2022","unstructured":"Lee, J. M., MacDonald, M. E. & Gusella, J. F. Inherited HTT CAG repeat length does not have a major impact on Huntington disease duration. Am. J. Hum. Genet. 109, 1338\u20131340 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"2191_CR7","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1093\/hmg\/ddg352","volume":"12","author":"L Kennedy","year":"2003","unstructured":"Kennedy, L. et al. Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum. Mol. Genet. 12, 3359\u20133367 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"2191_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41588-024-01653-6","volume":"56","author":"K Matlik","year":"2024","unstructured":"Matlik, K. et al. Cell-type-specific CAG repeat expansions and toxicity of mutant Huntingtin in human striatum and cerebellum. Nat. Genet. 56, 383\u2013394 (2024).","journal-title":"Nat. Genet."},{"key":"2191_CR9","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.neuron.2023.12.009","volume":"112","author":"C Pressl","year":"2024","unstructured":"Pressl, C. et al. Selective vulnerability of layer 5a corticostriatal neurons in Huntington\u2019s disease. Neuron 112, 924\u2013941.e10 (2024).","journal-title":"Neuron"},{"key":"2191_CR10","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1093\/hmg\/ddp242","volume":"18","author":"M Swami","year":"2009","unstructured":"Swami, M. et al. Somatic expansion of the Huntington\u2019s disease CAG repeat in the brain is associated with an earlier age of disease onset. Hum. Mol. Genet. 18, 3039\u20133047 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"2191_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/JHD-200427","volume":"10","author":"EP Hong","year":"2021","unstructured":"Hong, E. P. et al. Huntington\u2019s disease pathogenesis: two sequential components. J. Huntingtons Dis. 10, 35\u201351 (2021).","journal-title":"J. Huntingtons Dis."},{"key":"2191_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41593-022-01033-5","volume":"25","author":"B McAllister","year":"2022","unstructured":"McAllister, B. et al. Exome sequencing of individuals with Huntington\u2019s disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset. Nat. Neurosci. 25, 446\u2013457 (2022).","journal-title":"Nat. Neurosci."},{"key":"2191_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47485-0","volume":"15","author":"ZL McLean","year":"2024","unstructured":"McLean, Z. L. et al. Splice modulators target PMS1 to reduce somatic expansion of the Huntington\u2019s disease-associated CAG repeat. Nat. Commun. 15, 3182 (2024).","journal-title":"Nat. Commun."},{"key":"2191_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39547-6","volume":"14","author":"S Kristmundsdottir","year":"2023","unstructured":"Kristmundsdottir, S. et al. Sequence variants affecting the genome-wide rate of germline microsatellite mutations. Nat. Commun. 14, 3855 (2023).","journal-title":"Nat. Commun."},{"key":"2191_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Huntington Study Group.","year":"1996","unstructured":"Huntington Study Group. Unified Huntington\u2019s Disease Rating Scale: reliability and consistency. Mov. Disord. 11, 136\u2013142 (1996).","journal-title":"Mov. Disord."},{"key":"2191_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.29.1.1","volume":"29","author":"I Shoulson","year":"1979","unstructured":"Shoulson, I. & Fahn, S. Huntington disease: clinical care and evaluation. Neurology 29, 1\u20133 (1979).","journal-title":"Neurology"},{"key":"2191_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1212\/WNL.54.2.452","volume":"54","author":"K Marder","year":"2000","unstructured":"Marder, K. et al. Rate of functional decline in Huntington\u2019s disease. Huntington Study Group. Neurology 54, 452\u2013458 (2000).","journal-title":"Neurology"},{"key":"2191_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ajhg.2022.03.004","volume":"109","author":"JM Lee","year":"2022","unstructured":"Lee, J. M. et al. Genetic modifiers of Huntington disease differentially influence motor and cognitive domains. Am. J. Hum. Genet. 109, 885\u2013899 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"2191_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.gene.2016.06.031","volume":"590","author":"E Nicolas","year":"2016","unstructured":"Nicolas, E., Golemis, E. A. & Arora, S. POLD1: central mediator of DNA replication and repair, and implication in cancer and other pathologies. Gene 590, 128\u2013141 (2016).","journal-title":"Gene"},{"key":"2191_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5582\/ddt.2014.01036","volume":"8","author":"T Nakatsubo","year":"2014","unstructured":"Nakatsubo, T. et al. Human mediator subunit MED15 promotes transcriptional activation. Drug Discov. Ther. 8, 212\u2013217 (2014).","journal-title":"Drug Discov. Ther."},{"key":"2191_CR21","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nature04942","volume":"442","author":"F Yang","year":"2006","unstructured":"Yang, F. et al. An ARC\/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. Nature 442, 700\u2013704 (2006).","journal-title":"Nature"},{"key":"2191_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/00041444-200409000-00010","volume":"14","author":"HK Sandhu","year":"2004","unstructured":"Sandhu, H. K., Hollenbeck, N., Wassink, T. H. & Philibert, R. A. An association study of PCQAP polymorphisms and schizophrenia. Psychiatr. Genet. 14, 169\u2013172 (2004).","journal-title":"Psychiatr. Genet."},{"key":"2191_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41525-022-00317-w","volume":"7","author":"SV Lobanov","year":"2022","unstructured":"Lobanov, S. V. et al. Huntington\u2019s disease age at motor onset is modified by the tandem hexamer repeat in TCERG1. NPJ Genom. Med. 7, 53 (2022).","journal-title":"NPJ Genom. Med."},{"key":"2191_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/humu.10040","volume":"19","author":"ZQ Yuan","year":"2002","unstructured":"Yuan, Z. Q. et al. Polymorphisms and HNPCC: PMS2\u2013MLH1 protein interactions diminished by single nucleotide polymorphisms. Hum. Mutat. 19, 108\u2013113 (2002).","journal-title":"Hum. Mutat."},{"key":"2191_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajhg.2020.05.012","volume":"107","author":"KH Kim","year":"2020","unstructured":"Kim, K. H. et al. Genetic and functional analyses point to FAN1 as the source of multiple Huntington disease modifier effects. Am. J. Hum. Genet. 107, 96\u2013110 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"2191_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2322924121","volume":"121","author":"KH Kim","year":"2024","unstructured":"Kim, K. H. et al. Posttranscriptional regulation of FAN1 by miR-124-3p at rs3512 underlies onset-delaying genetic modification in Huntington\u2019s disease. Proc. Natl Acad. Sci. USA 121, e2322924121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2191_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/JHD-200426","volume":"10","author":"VC Wheeler","year":"2021","unstructured":"Wheeler, V. C. & Dion, V. Modifiers of CAG\/CTG repeat instability: insights from mammalian models. J. Huntingtons Dis. 10, 123\u2013148 (2021).","journal-title":"J. Huntingtons Dis."},{"key":"2191_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41588-024-02054-5","volume":"57","author":"R Mouro Pinto","year":"2025","unstructured":"Mouro Pinto, R. et al. In vivo CRISPR\u2013Cas9 genome editing in mice identifies genetic modifiers of somatic CAG repeat instability in Huntington\u2019s disease. Nat. Genet. 57, 314\u2013322 (2025).","journal-title":"Nat. Genet."},{"key":"2191_CR29","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1093\/nar\/gkf664","volume":"30","author":"J Lee","year":"2002","unstructured":"Lee, J. et al. An upstream open reading frame impedes translation of the huntingtin gene. Nucleic Acids Res. 30, 5110\u20135119 (2002).","journal-title":"Nucleic Acids Res."},{"key":"2191_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.cell.2024.11.038","volume":"188","author":"RE Handsaker","year":"2025","unstructured":"Handsaker, R. E. et al. Long somatic DNA-repeat expansion drives neurodegeneration in Huntington disease. Cell 188, 623\u2013639.e19 (2025).","journal-title":"Cell"},{"key":"2191_CR31","volume":"3","author":"J Dawson","year":"2022","unstructured":"Dawson, J. et al. A probable cis-acting genetic modifier of Huntington disease frequent in individuals with African ancestry. HGG Adv. 3, 100130 (2022).","journal-title":"HGG Adv"},{"key":"2191_CR32","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.4161\/rna.26706","volume":"10","author":"TA Gipson","year":"2013","unstructured":"Gipson, T. A., Neueder, A., Wexler, N. S., Bates, G. P. & Housman, D. Aberrantly spliced HTT, a new player in Huntington\u2019s disease pathogenesis. RNA Biol. 10, 1647\u20131652 (2013).","journal-title":"RNA Biol."},{"key":"2191_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s10020-024-00801-2","volume":"30","author":"F Hoschek","year":"2024","unstructured":"Hoschek, F. et al. Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissues. Mol. Med. 30, 36 (2024).","journal-title":"Mol. Med."},{"key":"2191_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cell.2018.08.068","volume":"175","author":"BG Bruneau","year":"2018","unstructured":"Bruneau, B. G. & Nora, E. P. Chromatin domains go on repeat in disease. Cell 175, 38\u201340 (2018).","journal-title":"Cell"},{"key":"2191_CR35","doi-asserted-by":"publisher","first-page":"e0227464","DOI":"10.1371\/journal.pone.0227464","volume":"15","author":"P Rudich","year":"2020","unstructured":"Rudich, P., Watkins, S. & Lamitina, T. PolyQ-independent toxicity associated with novel translational products from CAG repeat expansions. PLoS ONE 15, e0227464 (2020).","journal-title":"PLoS ONE"},{"key":"2191_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/10409238.2020.1841726","volume":"56","author":"JL Schwartz","year":"2021","unstructured":"Schwartz, J. L., Jones, K. L. & Yeo, G. W. Repeat RNA expansion disorders of the nervous system: post-transcriptional mechanisms and therapeutic strategies. Crit. Rev. Biochem. Mol. Biol. 56, 31\u201353 (2021).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"2191_CR37","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ajhg.2021.03.011","volume":"108","author":"C Depienne","year":"2021","unstructured":"Depienne, C. & Mandel, J. L. 30 years of repeat expansion disorders: What have we learned and what are the remaining challenges? Am. J. Hum. Genet. 108, 764\u2013785 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"2191_CR38","doi-asserted-by":"publisher","first-page":"667420","DOI":"10.3389\/fneur.2021.667420","volume":"12","author":"S Sathe","year":"2021","unstructured":"Sathe, S. et al. Enroll-HD: an integrated clinical research platform and worldwide observational study for Huntington\u2019s disease. Front. Neurol. 12, 667420 (2021).","journal-title":"Front. Neurol."},{"key":"2191_CR39","doi-asserted-by":"publisher","first-page":"e200111","DOI":"10.1212\/NXG.0000000000200111","volume":"9","author":"DR Langbehn","year":"2023","unstructured":"Langbehn, D. R., Sathe, S. S., Loy, C., Sampaio, C. & McCusker, E. A. A phenotypic atlas for Huntington disease based on data from the Enroll-HD Cohort Study. Neurol. Genet. 9, e200111 (2023).","journal-title":"Neurol. Genet."},{"key":"2191_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/mcpr.1993.1034","volume":"7","author":"JP Warner","year":"1993","unstructured":"Warner, J. P., Barron, L. H. & Brock, D. J. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington\u2019s disease chromosomes. Mol. Cell. Probes 7, 235\u2013239 (1993).","journal-title":"Mol. Cell. Probes"},{"key":"2191_CR41","doi-asserted-by":"publisher","unstructured":"Correia, K. HTT-Characterization: htt_trinucleotide_characterize. Zenodo https:\/\/doi.org\/10.5281\/zenodo.14885069 (2025).","DOI":"10.5281\/zenodo.14885069"},{"key":"2191_CR42","doi-asserted-by":"publisher","unstructured":"Ciosi, M. et al. Library preparation and MiSeq sequencing for the genotyping-by-sequencing of the Huntington disease HTT exon one trinucleotide repeat and the quantification of somatic mosaicism. Protoc. Exch. https:\/\/doi.org\/10.21203\/rs.2.1581\/v2 (2018).","DOI":"10.21203\/rs.2.1581\/v2"},{"key":"2191_CR43","doi-asserted-by":"publisher","unstructured":"Loay, H. et al. RGT: V1.0. Zenodo https:\/\/doi.org\/10.5281\/zenodo.14865581 (2025).","DOI":"10.5281\/zenodo.14865581"},{"key":"2191_CR44","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1212\/WNL.0000000000004743","volume":"89","author":"SA Schobel","year":"2017","unstructured":"Schobel, S. A. et al. Motor, cognitive, and functional declines contribute to a single progressive factor in early HD. Neurology 89, 2495\u20132502 (2017).","journal-title":"Neurology"},{"key":"2191_CR45","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/ng.2310","volume":"44","author":"X Zhou","year":"2012","unstructured":"Zhou, X. & Stephens, M. Genome-wide efficient mixed-model analysis for association studies. Nat. Genet. 44, 821\u2013824 (2012).","journal-title":"Nat. Genet."},{"key":"2191_CR46","doi-asserted-by":"publisher","first-page":"731","DOI":"10.21105\/joss.00731","volume":"3","author":"S Turner","year":"2018","unstructured":"Turner, S. qqman: an R package for visualizing GWAS results using Q\u2013Q and Manhattan plots. J. Open Source Softw. 3, 731 (2018).","journal-title":"J. Open Source Softw."},{"key":"2191_CR47","doi-asserted-by":"publisher","unstructured":"Ciosi, M. GWA6_BloodSomaticExpansionRatioPhenotype. Zenodo https:\/\/doi.org\/10.5281\/zenodo.14860920 (2025).","DOI":"10.5281\/zenodo.14860920"},{"key":"2191_CR48","doi-asserted-by":"publisher","unstructured":"McLean, Z. H. instability: Natcomms. Zenodo https:\/\/doi.org\/10.5281\/zenodo.10825847 (2024).","DOI":"10.5281\/zenodo.10825847"},{"key":"2191_CR49","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat. Genet. 54, 412\u2013436 (2022).","journal-title":"Nat. Genet."},{"key":"2191_CR50","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2191_CR51","doi-asserted-by":"publisher","first-page":"e1004219","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"2191_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nn.3922","volume":"18","author":"Network Pathway Analysis Subgroup of Psychiatric Genomics Consortium.","year":"2015","unstructured":"Network Pathway Analysis Subgroup of Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat. Neurosci. 18, 199\u2013209 (2015).","journal-title":"Nat. Neurosci."},{"key":"2191_CR53","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1093\/hmg\/ddx286","volume":"26","author":"JM Lee","year":"2017","unstructured":"Lee, J. M. et al. A modifier of Huntington\u2019s disease onset at the MLH1 locus. Hum. Mol. Genet. 26, 3859\u20133867 (2017).","journal-title":"Hum. Mol. Genet."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02191-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02191-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02191-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T13:03:31Z","timestamp":1749819811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02191-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2191"],"URL":"https:\/\/doi.org\/10.1038\/s41588-025-02191-5","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.F.G. and V.C.W. were founding scientific advisory board members with a financial interest in Triplet Therapeutics. Their financial interests were reviewed and are managed by Massachusetts General Hospital (MGH) and MGB in accordance with their conflict of interest policies. J.F.G. consults for Transine Therapeutics (dba Harness Therapeutics), has previously provided paid consulting services to Wave Therapeutics USA, Biogen and Pfizer, and receives research funding from Pfizer. V.C.W. is a scientific advisory board member of LoQus23 Therapeutics and has provided paid consulting services to Acadia Pharmaceuticals, Alnylam, Biogen, Passage Bio and Rgenta Therapeutics. V.C.W. and R.M.P. have received research support from Pfizer. J.-M.L. consults for GenKOre and serves on the scientific advisory board of GenEdit. Within the last 36 months, D.G.M. has been a scientific consultant and\/or received an honoraria or grants from AMO Pharma, Dyne, F. Hoffman\u2013La Roche, LoQus23, MOMA Therapeutics, Novartis, Ono Pharmaceuticals, Pfizer Pharmaceuticals, Rgenta Therapeutics, Sanofi, Sarepta Therapeutics, Script Biosciences, Triplet Therapeutics and Vertex Pharmaceuticals. D.G.M. also had research contracts with AMO Pharma and Vertex Pharmaceuticals. J.D.L. is a paid Advisory Board member for F. Hoffmann\u2013La Roche and uniQure biopharma and is a paid consultant for Vaccinex, Wave Life Sciences USA, Genentech, Triplet and PTC Therapeutics. T.H.M. is an associate member of the scientific advisory board of LoQus23 Therapeutics and has consulted for Transine Therapeutics (dba Harness Therapeutics). P.H. is a member of the Enroll-HD Scientific Review Committee. S.K. and C.S. are employed by CHDI Management as advisors to the CHDI Foundation. E.R.D. has provided consulting services to Abbott, Abbvie, Acadia, Acorda Therapeutics, Biogen, Biohaven Pharmaceuticals, BioSensics, Boehringer Ingelheim, Caraway Therapeutics, Cerevance, CuraSen, DConsult2, Denali Therapeutics, Eli Lilly, Genentech, Health & Wellness Partners, HMP Education, Karger, KOL groups, Life Sciences Consultant, Mediflix, Medrhythms, Merck, Mitsubishi Tanabe Pharma America, MJH Holdings, NACCME Novartis, Otsuka, Praxis Medicine, Sanofi, Seelos Therapeutics, Spark Therapeutics, Springer Healthcare, Theravance Biopharmaceuticals and WebMD. He has received grant support from Averitas Pharma, Biogen, Burroughs Wellcome Fund, Pfizer, Photopharmics and Roche and has an ownership interest in Included Health, Mediflix, SemCap and Synapticure. G.B.L. has provided consulting services, scientific advice, scientific advisory board functions, independent data monitoring committee services and\/or lectures for Acadia Pharmaceuticals, Affiris, Allergan, Alnylam, Amarin, AOP Orphan Pharmaceuticals, Bayer Pharma, Boehringer Ingelheim, CHDI Foundation, Deutsche Huntington-Hilfe, Desitin, Genentech, Genzyme, GlaxoSmithKline, F. Hoffmann\u2013La Roche, Ipsen, ISIS Pharma (IONIS), Lilly, Lundbeck, Medesis, Medivation, Medtronic, NeuraMetrix, Neurosearch, Novartis, Pfizer, Prana Biotechnology, Prilenia, PTC Therapeutics, Raptor, Remix Therapeutics, Rh\u00f4ne-Poulenc Rorer, Roche Pharma AG Deutschland, Sage Therapeutics, Sanofi-Aventis, Sangamo\/Shire, Siena Biotech, Takeda, Temmler Pharma GmbH, Teva, Triplet Therapeutics, Trophos, UniQure and Wave Life Sciences. R.H.M. is a paid advisory board member for Rgenta Therapeutics and is on the scientific advisory board with financial interests in Gatehouse Bio. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}